19 Sep 2024
Anti-racism statement calls for improved accountability and trusted reporting systems
This week we released our anti-racism position statement which calls for everyone in the healthcare system to take responsibility for tackling racism and ensuring systems are in place to deal with racism in a culturally safe way.
19 Sep 2024
DVA survey to assist AMA’s support of veterans’ health
AMA non-GP specialists are invited to take part in a brief survey to help inform the AMA’s policy positions and advocacy to support veterans access to medical care.
19 Sep 2024
DVA survey to assist AMA’s support of veterans’ health
AMA non-GP specialists are invited to take part in a brief survey to help inform the AMA’s policy positions and advocacy to support veterans access to medical care.
26 Sep 2024
Join our webinar with PSR Director Dr Antonio Di Dio
AMA members are invited to join our webinar to hear from Professional Services Review Director Dr Antonio Di Dio.
19 Sep 2024
National Medicines Symposium
This year’s National Medicines Symposium is exploring appropriate use of medicines in an ageing population.
12 Sep 2024
AMA welcomes ban on use of genetic tests to refuse insurance cover
AMA President Professor Steve Robson described the Australian Government’s ban on insurers using genetic tests to refuse coverage as “fantastic news for Australians and for their health system”.
12 Sep 2024
Latest AMA Diversity Report on Gender shows continued improvement in meeting targets
The AMA’s sixth gender report was released this week.
12 Sep 2024
AMA President urges government action on veterans’ royal commission
AMA President Professor Steve Robson, a former medical officer of the Royal Australian Navy, who served in the first Gulf War, has called for the recommendations of the Royal Commission into Defence and Veteran Suicide to be adopted.
12 Sep 2024
Doctors in Training forum looks at examination and assessment feedback
AMA CDT Chair Dr Sanjay Hettige has provided an update from the latest CDT trainee forum.
12 Sep 2024
RCPA develops guidance for pharmacogenomic testing
Guidance for the cutting edge of personalised medicines.